Suppr超能文献

依托泊苷在人肝微粒体中的葡萄糖醛酸化反应由尿苷二磷酸葡萄糖醛酸基转移酶1A1特异性催化。

Glucuronidation of etoposide in human liver microsomes is specifically catalyzed by UDP-glucuronosyltransferase 1A1.

作者信息

Watanabe Yuichiro, Nakajima Miki, Ohashi Noriko, Kume Toshiyuki, Yokoi Tsuyoshi

机构信息

Division of Drug Metabolism, Faculty of Pharmaceutical Sciences, Kanazawa University, Kanazawa, Japan.

出版信息

Drug Metab Dispos. 2003 May;31(5):589-95. doi: 10.1124/dmd.31.5.589.

Abstract

A metabolite formed by incubation of human liver microsomes, etoposide, and UDP-glucuronic acid was identified as etoposide glucuronide by liquid chromatography-tandem mass spectrometry analysis. According to the derivatization with trimethylsilylimidazole (Tri-Sil-Z), it was confirmed that the glucuronic acid is linked to an alcoholic hydroxyl group of etoposide and not to a phenolic group. Among nine recombinant human UGT isoforms (UGT1A1, UGT1A3, UGT1A4, UGT1A6, UGT1A8, UGT1A9. UGT1A10, UGT2B7, and UGT2B15), only UGT1A1 exhibited the catalytic activity of etoposide glucuronidation. The enzyme kinetics in pooled human liver microsomes and recombinant UGT1A1 microsomes showed a typical Michaelis-Menten plot. The kinetic parameters of etoposide glucuronidation were K(m) = 439.6 +/- 70.7 microM and V(max) = 255.6 +/- 19.2 pmol/min/mg of protein in human liver microsomes and K(m) = 503.2 +/- 110.2 microM and V(max) = was 266.5 +/- 28.6 pmol/min/mg of protein in recombinant UGT1A1. The etoposide glucuronidation in pooled human liver microsomes was inhibited by bilirubin (IC(50) = 31.7 microM) and estradiol (IC(50) = 34 microM) as typical substrates for UGT1A1. The inhibitory effects of 4-nitrophenol (IC(50) = 121.0 microM) as a typical substrate for UGT1A6 and UGT1A9, imipramine (IC(50) = 393.8 microM) as a typical substrate for UGT1A3 and UGT1A4, and morphine (IC(50) = 109.3 microM) as a typical substrate for UGT2B7 were relatively weak. The interindividual difference in etoposide glucuronidation in 13 human liver microsomes was 78.5-fold (1.4-109.9 pmol/min/mg of protein). The etoposide glucuronidation in 10 to 13 human liver microsomes was significantly correlated with beta-estradiol-3-glucuronidation (r = 0.841, p < 0.01), bilirubin glucuronidation (r = 0.935, p < 0.01), and the immunoquantified UGT1A1 protein content (r = 0.800, p < 0.01). These results demonstrate that etoposide glucuronidation in human liver microsomes is specifically catalyzed by UGT1A1.

摘要

通过液相色谱-串联质谱分析,鉴定出由人肝微粒体、依托泊苷和尿苷二磷酸葡萄糖醛酸孵育形成的一种代谢物为依托泊苷葡萄糖醛酸苷。根据用三甲基硅咪唑(Tri-Sil-Z)进行的衍生化反应,证实葡萄糖醛酸与依托泊苷的醇羟基相连,而非酚羟基。在9种重组人UGT同工型(UGT1A1、UGT1A3、UGT1A4、UGT1A6、UGT1A8、UGT1A9、UGT1A10、UGT2B7和UGT2B15)中,只有UGT1A1表现出依托泊苷葡萄糖醛酸化的催化活性。在混合人肝微粒体和重组UGT1A1微粒体中的酶动力学呈现典型的米氏曲线。依托泊苷葡萄糖醛酸化的动力学参数在人肝微粒体中为K(m)=439.6±70.7微摩尔,V(max)=255.6±19.2皮摩尔/分钟/毫克蛋白质,在重组UGT1A1中为K(m)=503.2±110.2微摩尔,V(max)=266.5±28.6皮摩尔/分钟/毫克蛋白质。混合人肝微粒体中的依托泊苷葡萄糖醛酸化受到胆红素(IC(50)=31.7微摩尔)和雌二醇(IC(50)=34微摩尔)的抑制,它们是UGT1A1的典型底物。4-硝基苯酚(IC(50)=121.0微摩尔)作为UGT1A6和UGT1A9的典型底物、丙咪嗪(IC(50)=393.8微摩尔)作为UGT1A3和UGT1A4的典型底物以及吗啡(IC(50)=109.3微摩尔)作为UGT2B7的典型底物的抑制作用相对较弱。13个人肝微粒体中依托泊苷葡萄糖醛酸化的个体间差异为78.5倍(1.4-109.9皮摩尔/分钟/毫克蛋白质)。10至13个人肝微粒体中的依托泊苷葡萄糖醛酸化与β-雌二醇-3-葡萄糖醛酸化(r=0.841,p<0.01)、胆红素葡萄糖醛酸化(r=0.935,p<0.01)以及免疫定量的UGT1A1蛋白含量(r=0.800,p<0.01)显著相关。这些结果表明,人肝微粒体中的依托泊苷葡萄糖醛酸化是由UGT1A1特异性催化的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验